JHSM

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

EndNote Style
Index
Original Article
Incidental focal 18F-FDG uptake in colorectal locations on PET/CT for oncologic reasons: pathologic correlation with endoscopic finding
Aims: Incidental focal 18-fluorodeoxyglucose (18F-FDG) uptake in the colorectal region on positron emission tomography/computed tomography (PET/CT) may indicate premalignant lesions, such as adenomas or malignancies. Early detection and diagnosis are crucial for cancer prevention. This study aimed to assess the characteristics of incidental focal colonic FDG uptake associated with benign, premalignant, and malignant lesions, and to determine when colonoscopy is necessary.
Methods: A retrospective review of PET/CT reports was conducted on 5.380 patients with confirmed or suspected malignancies who underwent whole-body 18F-FDG PET/CT between January 2019 and April 2024. Patients exhibiting focal colonic 18F-FDG uptake and subsequently referred for colonoscopy were included in this study.
Results: Among 110 patients who underwent colonoscopy, 63 (57.3%) had adenomas and 14 (12.7%) had malignant tumors. The receiver operating characteristic (ROC) curve based on the maximum standardized uptake value (SUVmax) showed an AUC of 0.958. A cutoff value of 13.80 was optimal for distinguishing malignant lesions from nonmalignant lesions, with a sensitivity of 92%, specificity of 89%, positive predictive value of 56%, and negative predictive value of 98%. The SUVmax significantly differentiated malignancy from other colonoscopic findings (p<0.001). No significant differences were observed between adenomas and benign or physiological findings (p>0.05).
Conclusion: The colonoscopy results indicated that malignant lesions had significantly elevated SUVmax values compared to other lesion types or physiological uptake. However, the SUVmax was not sufficient to distinguish benign lesions from adenomas. Therefore, all incidental colonic findings should be thoroughly assessed, and lesions with SUVmax ?13.80 should be promptly evaluated.


1. Xia X, Wang Y, Yuan J, et al. Baseline SUVmax of 18F-FDG PET-CT indicates prognosis of extranodal natural killer/T-cell lymphoma. Medicine (Baltimore). 2020;99(37):e22143. doi:10.1097/md.00000000000 22143
2. Arikan AE, Makay O, Teksoz S, et al. Efficacy of PET-CT in the prediction of metastatic adrenal masses that are detected on follow-up of the patients with prior nonadrenal malignancy: a nationwide multicenter case-control study. Medicine (Baltimore). 2022;101(34):e30214. doi:10.1097/md.0000000000030214
3. Hosni MN, Kassas M, Itani MI, et al. The clinical significance of incidental GIT uptake on PET/CT: radiologic, endoscopic, and pathologic correlation. Diagnostics (Basel). Mar 30 2023;13(7)1297. doi: 10.3390/diagnostics13071297
4. Sagnes J, Battistella P, Paunet T, Mariano-Goulart D, Kucharczak F. Evaluation of 18-FDG PET diagnostic capabilities for cancer screening in heart transplant patients, a retrospective study. Medicine (Baltimore). 2023;102(39):e35296. doi:10.1097/md.0000000000035296
5. Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics. 2004;24(5):1411-1431. doi:10.1148/rg.245035725
6. Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology. 2002;224(3):783-787. doi:10.1148/radiol.2243011214
7. Penz D, Pammer D, Waldmann E, et al. Association between endoscopist adenoma detection rate and serrated polyp detection: Retrospective analysis of over 200,000 screening colonoscopies. Endosc Int Open. 2024; 12(4):e488-e497. doi:10.1055/a-2271-1929
8. Treglia G, Taralli S, Salsano M, Muoio B, Sadeghi R, Giovanella L. Prevalence and malignancy risk of focal colorectal incidental uptake detected by (18) F-FDG-PET or PET/CT: a meta-analysis. Radiol Oncol. 2014;48(2):99-104. doi:10.2478/raon-2013-0035
9. Bielawska B, Hookey LC, Sutradhar R, et al. Anesthesia assistance in outpatient colonoscopy and risk of aspiration pneumonia, bowel perforation, and splenic injury. Gastroenterology. 2018;154(1):77-85. doi: 10.1053/j.gastro.2017.08.043
10. Young CJ, Zahid A, Choy I, Thompson JF, Saw RPM. Incidental detection of colorectal lesions by FDG PET/CT scans in melanoma patients. Eur J Surg Oncol. Nov 2017;43(11):2163-2169. doi:10.1016/j.ejso.2017.09.012
11. Babat I, Polat H, Umar Gursu R, et al. The effect of mutation status, pathological features and tumor location on prognosis ın patients with colorectal cancer. Rev Assoc Med Bras (1992). 2021;67(2):185-189. doi:10. 1590/1806-9282.67.02.20200321
12. Mainenti PP, Iodice D, Segreto S, et al. Colorectal cancer and 18FDG-PET/CT: what about adding the T to the N parameter in loco-regional staging? World J Gastroenterol. 21 2011;17(11):1427-1433. doi:10.3748/wjg.v17.i11.1427
13. Lee H, Hwang KH, Kwon KA. Assessment of incidental focal colorectal uptake by analysis of fluorine-18 fluorodeoxyglucose positron emission tomography parameters. World J Clin Cases. 2022;10(17):5634-5645. doi: 10.12998/wjcc.v10.i17.5634
14. Purandare NC, Gawade SK, Puranik AD, Agrawal A, Shah S, Rangarajan V. Etiology and significance of incidentally detected focal colonic uptake on FDG PET/CT. Indian J Radiol Imaging. 2012;22(4):260-6. doi:10.4103/ 0971-3026.111476
15. G&ouml;kden Y, &Ouml;z&uuml;lker F, &Ouml;z&uuml;lker T. Prevalence and clinical significance of incidental focal (18) F-FDG uptake in colon on PET/CT imaging. Mol Imaging Radionucl Ther. 2022;31(2):96-103. doi:10.4274/mirt.galenos. 2022.38247
16. Farquharson AL, Chopra A, Ford A, Matthews S, Amin SN, De Noronha R. Incidental focal colonic lesions found on (18) fluorodeoxyglucose positron emission tomography/computed tomography scan: further support for a national guideline on definitive management. Colorectal Dis. 2012;14(2):e56-63. doi:10.1111/j.1463-1318.2011.02760.x
17. Fuertes J, Montagut C, Bullich S, et al. Incidental focal uptake in colorectal location on oncologic &sup1;8FDG PET and PET/CT studies: histopathological findings and clinical significances. Rev Esp Med Nucl Imagen Mol. 2015;34(2):95-101. doi:10.1016/j.remn.2014.07.008
18. van Hoeij FB, Keijsers RG, Loffeld BC, Dun G, Stadhouders PH, Weusten BL. Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy? Eur J Nucl Med Mol Imag. 2015;42(1):66-71. doi:10.1007/s00259-014-2887-3
19. Drenth JP, Nagengast FM, Oyen WJ. Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med. 2001;28(12):1766-1769. doi:10.1007/s002590100645
20. Jayaprakasam VS, Paroder V, Sch&ouml;der H. Variants and pitfalls in PET/CT imaging of gastrointestinal cancers. Semin Nucl Med. 2021;51(5):485-501. doi:10.1053/j.semnuclmed.2021.04.001
21. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National polyp study workgroup. N Engl J Med. 1993;329(27):1977-1981. doi:10.1056/nejm199312303292701
22. Treglia G, Calcagni ML, Rufini V, et al. Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature. Colorectal Dis. 2012;14(2):174-180. doi:10.1111/j. 1463-1318.2011.02588.x
23. Gutman F, Alberini JL, Wartski M, et al. Incidental colonic focal lesions detected by FDG PET/CT. AJR Am J Roentgenol. 2005;185(2):495-500. doi:10.2214/ajr.185.2.01850495
24. Luboldt W, Volker T, Wiedemann B, et al. Detection of relevant colonic neoplasms with PET/CT: promising accuracy with minimal CT dose and a standardised PET cut-off. Eur Radiol. 2010;20(9):2274-2285. doi: 10.1007/s00330-010-1772-0
25. Ozaslan E, Kiziltepe M, Addulrezzak U, et al. Is SUVmax of (18)F-FDG PET/CT predictive factor for malignancy in gastrointestinal tract? Niger J Clin Pract. 2021;24(8):1217-1224. doi:10.4103/njcp.njcp_637_18
26. Esmer AC, &Ouml;ks&uuml;zoğlu K, Şen F, et al. Evaluation of colonoscopic results of patients with incidental colonic FDG uptake in PET/CT imaging. World J Surg. 2023;47(10):2532-2541. doi:10.1007/s00268-023-07135-w
Volume 8, Issue 1, 2025
Page : 109-114
_Footer